[HTML] mdpi.com

[HTML][HTML] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - mdpi.com
The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …
被引用次数：27 相关文章

The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - cir.nii.ac.jp
抄録< jats: p> The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

The Pharmacological Potential of Adenosine A 2A Receptor Antagonists for Treating Parkinson's Disease.

A Mori, JF Chen, S Uchida, C Durlach, SM King… - …, 2022 - search.ebscohost.com
The adenosine A< sub> 2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …
[PDF] kcl.ac.uk

[PDF][PDF] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - 2022 - kclpure.kcl.ac.uk
The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, C Jiang-Fan, S Uchida, C Durlach… - …, 2022 - search.proquest.com
The adenosine A 2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida… - Molecules (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
The adenosine A 2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease.

A Mori, JF Chen, S Uchida, C Durlach… - Molecules (Basel …, 2022 - europepmc.org
The adenosine A 2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …
[HTML] nih.gov

[HTML][HTML] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - ncbi.nlm.nih.gov
The adenosine A 2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …
[PDF] kcl.ac.uk

[PDF][PDF] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - kclpure.kcl.ac.uk
The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …